These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 34576896)
1. Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant Camens S; Liu S; Hon K; Bouras GS; Psaltis AJ; Wormald PJ; Vreugde S Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576896 [TBL] [Abstract][Full Text] [Related]
2. Activity of Bacteriophages in Removing Biofilms of Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773 [No Abstract] [Full Text] [Related]
3. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential. Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933 [TBL] [Abstract][Full Text] [Related]
4. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Rossitto M; Fiscarelli EV; Rosati P Front Microbiol; 2018; 9():775. PubMed ID: 29780361 [TBL] [Abstract][Full Text] [Related]
5. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480 [TBL] [Abstract][Full Text] [Related]
6. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice. Vinodkumar CS; Kalsurmath S; Neelagund YF Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa. Ong SP; Azam AH; Sasahara T; Miyanaga K; Tanji Y J Biosci Bioeng; 2020 Jun; 129(6):693-699. PubMed ID: 32107153 [TBL] [Abstract][Full Text] [Related]
8. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis. Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm. Adnan M; Ali Shah MR; Jamal M; Jalil F; Andleeb S; Nawaz MA; Pervez S; Hussain T; Shah I; Imran M; Kamil A Biologicals; 2020 Jan; 63():89-96. PubMed ID: 31685418 [TBL] [Abstract][Full Text] [Related]
10. Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Martin I; Morales S; Alton EWFW; Davies JC Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978460 [TBL] [Abstract][Full Text] [Related]
12. Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model. Rezk N; Abdelsattar AS; Elzoghby D; Agwa MM; Abdelmoteleb M; Aly RG; Fayez MS; Essam K; Zaki BM; El-Shibiny A J Genet Eng Biotechnol; 2022 Sep; 20(1):133. PubMed ID: 36094767 [TBL] [Abstract][Full Text] [Related]
13. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions. Alves DR; Perez-Esteban P; Kot W; Bean JE; Arnot T; Hansen LH; Enright MC; Jenkins AT Microb Biotechnol; 2016 Jan; 9(1):61-74. PubMed ID: 26347362 [TBL] [Abstract][Full Text] [Related]
14. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
15. Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028 [TBL] [Abstract][Full Text] [Related]
16. Use of Phage Cocktail BFC 1.10 in Combination With Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant Racenis K; Rezevska D; Madelane M; Lavrinovics E; Djebara S; Petersons A; Kroica J Front Med (Lausanne); 2022; 9():851310. PubMed ID: 35547216 [TBL] [Abstract][Full Text] [Related]
17. Isolation and Characterization of Lytic Bacteriophage Against Multi-drug Resistant Pseudomonas aeruginosa. Maharjan A; Nepal R; Dhungana G; Parajuli A; Regmi M; Upadhyaya E; Mandal D; Shrestha M; Pradhan P; Manandhar KD; Malla R J Nepal Health Res Counc; 2022 Mar; 19(4):717-724. PubMed ID: 35615828 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the novel broad-spectrum lytic phage Phage_Pae01 and its antibiofilm efficacy against Shi Z; Hong X; Li Z; Zhang M; Zhou J; Zhao Z; Qiu S; Liu G Front Microbiol; 2024; 15():1386830. PubMed ID: 39091310 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of lytic bacteriophages against Majdani R; Shams Ghahfarokhi E Iran J Microbiol; 2022 Apr; 14(2):203-213. PubMed ID: 35765555 [TBL] [Abstract][Full Text] [Related]